This article has Open Peer Review reports available.
Atypical facial pain in multiple sclerosis caused by spinal cord seizures: a case report and review of the literature
© Gupta and Burchiel. 2016
Received: 2 December 2015
Accepted: 30 March 2016
Published: 20 April 2016
Pain is a very commonly reported symptom and often drives patients to seek medical attention; however, it can prove a very difficult diagnostic conundrum and even more challenging to treat effectively. Accurately determining the primary pain generator is key, as certain conditions have efficacious medical and surgical treatments. We present a rare case of a man with multiple sclerosis presenting with spinal cord seizures causing dermatomal pain. While pain has been reported in the context of motor symptoms attributed to spinal cord seizures in a small number of spinal cord conditions, this case represents the first report of pain exclusively associated with spinal cord demyelination in multiple sclerosis.
We present the case of a 60-year-old Caucasian male patient with multiple sclerosis who reported a 5-year history of progressive pain in his left retroauricular region and superior left shoulder. He described this pain as sharp, episodic, and unrelenting and he was referred for consideration for surgical treatment of trigeminal neuralgia. He had no evidence of trigeminal nerve root pathology on magnetic resonance imaging, but did show dorsolateral spinal cord demyelination at the C3–4 level. His symptoms therefore represent an unusual presentation of spinal cord seizures.
Spinal cord seizures are rarely reported in multiple sclerosis and typically present with focal motor seizures. These have been reported to present with cramping dysesthesia and pruritus, though rarely with primary pain. Knowledge of uncommon pain presentations is critical for the increasing number of primary care physicians caring for patients with such chronic neurological diseases as it will guide management and referral patterns. This knowledge is also important for the treating neurologists and neurosurgeons. Neurosurgical intervention for trigeminal neuralgia poses considerable surgical risk, and it should be avoided where possible. Identifying the primary pain generator is, therefore, critical for accurate diagnosis and management.
Pain in the setting of multiple sclerosis (MS) is increasingly recognized, and can be caused by a range of pain syndromes, including headache and facial pain, Lhermitte’s sign, and neuropathic body pain, as well as pain related to tonic spasms and spasticity . One prominent and well-recognized cause of facial pain in MS is trigeminal neuralgia. Trigeminal neuralgia is frequently described by patients as a lancinating pain and/or burning dysesthesia and occurs in the facial trigeminal nerve dermatomes. While it is well recognized in the context of MS, trigeminal neuralgia occurs infrequently, with a prevalence of 1–3 % of patients with MS. A range of etiologies of trigeminal nerve dysfunction has been identified in the context of MS, including mass effect from tumors and neurovascular compression. However, a direct cause associated with MS is believed to be the demyelination of the trigeminal nerve root entry zone at the brainstem. The surgical management of trigeminal neuralgia in the setting of neurovascular compression is typically by open microvascular decompression; however, in the setting of MS, first-line management is often by percutaneous gangliolysis.
Our neurosurgery service received a referral for a 60-year-old man with MS for an unusual presentation of facial pain. He was referred with a diagnosis of trigeminal neuralgia and a request for surgical intervention. Upon evaluation, we noted that he had no evidence of trigeminal nerve root compression or demyelination on MRI, and clinically his pain was atypical for trigeminal neuralgia. We further reviewed an MRI of his cervical spine and noted dorsolateral demyelination at the clinically afflicted dermatome, leading to a diagnosis of spinal cord seizures, a rare and infrequently disorder associated with spinal cord demyelination in MS. Spinal cord seizures have also been reported in transverse myelopathy, traumatic spinal cord injury, and gliomas of the spinal cord [2–4]. The clinical manifestations reported are predominantly focal motor symptoms, including myoclonus and tonic spasm, occasionally accompanied by painful dysesthesia and pruritus . Transient pruritus has been described in the setting of spinal cord glioma in a dermatomal pattern; this was responsive to gabapentin, leading the authors to hypothesize a neurological basis for the symptoms . Prior case reports of patients with MS have documented spinal cord seizures with motor phenomena that afflict the myotomes corresponding with the region of the spinal cord affected by the demyelinated plaques [2, 3]. Primary pain syndromes caused by spinal cord demyelination are far less frequently reported [1, 5], and are thus they are often poorly recognized. We present this man’s case, discuss how these pain syndromes can be diagnostically differentiated, and evaluate the current medical and surgical treatment options.
A 60-year-old Caucasian man with a diagnosis of relapsing-remitting MS was evaluated in our Neurosurgery outpatient clinic. He described his initial symptoms as beginning 7 years ago, with altered sensorium that occurred while driving. He developed mild left-fingertip numbness 2 years later. An MRI of his brain was performed at that time to aid in diagnosing his neurological symptoms. This demonstrated periventricular white matter lesions, and he was diagnosed with MS. He was initially treated with interferon-beta; however, recently he has been experiencing injection fatigue and stated that he is considering a transition to oral medications. He also described left-sided ear pain and shoulder dysesthesia, which began 5 years ago. He had tried multiple medications for this neuropathic pain, including gabapentin, pregabalin, and carbamazepine, with little clinical relief. Based on the described location of the pain, he was diagnosed with trigeminal neuralgia and referred to our Neurosurgery service for consideration for surgical treatment.
We present the case of a patient with atypical facial pain in the setting of MS. He received a presumptive diagnosis of trigeminal neuralgia and was referred for surgical management. Upon review, we felt that his symptomatology was atypical for trigeminal neuralgia, with it predominantly affecting non-trigeminal dermatomes. A careful review of his MRI scan showed no evidence for trigeminal nerve pathology, and we identified an area of demyelination in the dorsolateral region of his cervical spinal cord in the region of his pain, which could have been localized to C3–4 dermatomes. We concluded that this region was the source of his pain and that his symptoms were a manifestation of spinal cord seizures. We therefore report a rare case of pain as a presentation of MS-associated spinal cord seizures.
Spinal cord seizures typically present with focal motor symptoms ; while burning dysesthesia has been described in the setting of tonic muscle spasms , episodic pain has not previously been reported as a primary presentation of spinal cord seizures. Our patient posed a diagnostic dilemma due to the clinical overlap in his symptoms with trigeminal neuralgia. We further discuss how these two syndromes can be diagnostically differentiated and the current medical and surgical treatment options. This case provides a critical opportunity to highlight patterns of symptomatology that can help distinguish between these two difficult-to-diagnose clinical entities, and direct investigation and treatment.
Trigeminal neuralgia is an uncommon occurrence in the setting of MS, affecting only 1–3 % of patients with MS. The mainstay of diagnosis and investigation for trigeminal neuralgia is by extensive clinical history, identifying the nature of the pain as well as localization to the trigeminal nerve distribution. MRI and MRA of the brain can identify compressive vascular structures, plaques, tumors, and other lesions affecting the trigeminal root entry zone.
Spinal cord seizures have been reported in MS, as well as in transverse myelopathy and traumatic spinal cord injury. These typically manifest as focal motor symptoms or myoclonus and tonic spasm, and they are occasionally accompanied by painful dysesthesia [2, 3]. Primary pain syndromes caused by spinal cord demyelination are rarely reported and poorly recognized; careful clinical examination and identifying spinal cord plaques on MRI can help guide diagnosis. Nerve conduction studies can also be helpful in excluding other conditions with similar presentations, such as radiculopathy attributable to nerve root compression. In our case, dermatomal pain outside the trigeminal dermatomes and the presence of a corresponding lesion in the dorsal horn of his cervical spinal cord led to the diagnosis of spinal cord seizures.
The substantia gelatinosa of the spinal cord and the spinal nucleus of the trigeminal nerve share both anatomical continuity and mechanisms in pain processing and the induction of neuropathic pain [6, 7]. Studies have demonstrated that transient receptor potential A1 and transient receptor potential vanilloid 1 are present in both locations and play a role in the communication of noxious stimuli to central pathways . Furthermore, neuronal transduction of noxious stimuli is modulated by c-fos in both the trigeminal nerve and the substantia gelatinosa [9, 10]. It is therefore possible that the processes that underpin the development of neuropathic pain in both pathologies share mechanistic overlap.
Both spinal cord seizures and trigeminal neuralgia can be treated medically with anticonvulsant medications [11, 12]. While trigeminal neuralgia can be treated surgically by microvascular decompression/neurolysis or gangliolysis , proven surgical treatments for spinal cord seizures are currently lacking. Experimental procedures include vagal nerve stimulation and spinal cord stimulation [14, 15]. Therefore, accurate diagnosis of the primary pain generator is critical in guiding therapy.
We have highlighted the diagnostic challenge posed by pain in patients with MS. We report an atypical presentation of pain caused by spinal cord seizures in the setting of MS, highlight the clinical distinction of spinal cord seizures from trigeminal neuralgia, and discuss the implications of accurate diagnosis for investigation and management.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Seixas D, Foley P, Palace J, Lima D, Ramos I, Tracey I. Pain in multiple sclerosis: a systematic review of neuroimaging studies. Neuroimage Clin. 2014;5:322–31.View ArticlePubMedPubMed CentralGoogle Scholar
- Cherrick A, Ellenberg M. Spinal cord seizures in transverse myelopathy: report of two cases. Arch Phys Med Rehabil. 1986;67:129–31.View ArticlePubMedGoogle Scholar
- Meythaler JM, Tuel SM, Cross LL. Spinal cord seizures: a possible cause of isolated myoclonic activity in traumatic spinal cord injury: case report. Paraplegia. 1991;29:557–60.View ArticlePubMedGoogle Scholar
- Wolking S, Lerche H, Dihné M. Episodic itch in a case of spinal glioma. BMC Neurol. 2013;13:124.View ArticlePubMedPubMed CentralGoogle Scholar
- Hellwig K, Lukas C, Brune N, Hoffmann V, Schimrigk S, Przuntek H, et al. Repeat intrathecal triamcinolone acetonide application reduces acute occurring painful dysesthesia in patients with relapsing remitting multiple sclerosis. Scientific World Journal. 2006;6:460–5.View ArticlePubMedGoogle Scholar
- Ren D. The role of trigeminal interpolaris-caudalis transition zone in persistent orofacial pain. Int Rev Neurobiol. 2011;97:207–25.View ArticlePubMedPubMed CentralGoogle Scholar
- Todd A. Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neurosci. 2010;11(12):823–36.View ArticlePubMedPubMed CentralGoogle Scholar
- Uta D, Furue H, Pickering AE, Rashid MH, Mizuguchi-Takase H, Katafuchi T, et al. TRPA1-expressing primary afferents synapse with a morphologically identified subclass of substantia gelatinosa neurons in the adult rat spinal cord. Eur J Neurosci. 2010;31:1960–73.View ArticlePubMedPubMed CentralGoogle Scholar
- Sugimoto T, He YF, Xiao C, Ichikawa H. c-fos induction in the subnucleus oralis following trigeminal nerve stimulation. Brain Res. 1998;783:158–62.View ArticlePubMedGoogle Scholar
- Sandkühler J, Treier AC, Liu XG, Ohnimus M. The massive expression of c-fos protein in spinal dorsal horn neurons is not followed by long-term changes in spinal nociception. Neuroscience. 1996;73:657–66.View ArticlePubMedGoogle Scholar
- Andrade C, Massano J, Guimarães J, Garrett MC. Stretching the limbs? Tonic spasms in multiple sclerosis. BMJ Case Rep. 2012;2012. doi:10.1136/bcr-2012-007513.
- Gibson J, White L. Denervation hyperpathia: a convulsive syndrome of the spinal cord responsive to carbamazepine therapy. J Neurosurg. 1971;35(3):287–90.View ArticlePubMedGoogle Scholar
- Miller JP, Magill ST, Acar F, Burchiel KJ. Predictors of long-term success after microvascular decompression for trigeminal neuralgia. J Neurosurg. 2009;110:620–6.View ArticlePubMedGoogle Scholar
- Tubbs RS, Killingsworth CR, Rollins DL, Smith WM, Ideker RE, Wellons JC, et al. Vagus nerve stimulation for induced spinal cord seizures: insights into seizure cessation. J Neurosurg. 2005;102(2 Suppl):213–7.View ArticlePubMedGoogle Scholar
- Burkey A, Abla‐Yao S. Successful treatment of central pain in a multiple sclerosis patient with epidural stimulation of the dorsal root entry zone. Pain Med. 2010;11:127–32.View ArticlePubMedGoogle Scholar